Skip to content

Clinical trials

Phase 3 Stroke trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: India Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20082
20092
20113
20132
20141
20161
20181
20192
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Christian Medical College and Hospital, Ludhiana, India3
Boehringer Ingelheim2
Pfizer2
Sanofi2
AstraZeneca1
Daiichi Sankyo1
Eli Lilly and Company1
H. Lundbeck A/S1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke23
Myocardial Infarction8
Atrial Fibrillation6
Cardiovascular Diseases6
Hyperlipidemias3
Embolism2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Atherosclerosis1
Brain Ischemia1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.